NCT07813637
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07813637
Title Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC (PSMA-013-001)
Acronym PSMA-013-001
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Janux Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field